Johnson & Johnson MedTech Tech Stack
Medical device manufacturer spanning surgery, orthopaedics, cardiovascular, and vision
Johnson & Johnson MedTech operates a portfolio of invasive medical devices across four core therapeutic areas, with active commercialization of intravascular lithotripsy and accelerated adoption of the Impella cardiac support platform. The hiring mix is heavily skewed toward sales (638 roles) relative to engineering (117), reflecting a post-acquisition integration and market-expansion phase rather than platform-building; pain points around portfolio adoption, network strategy, and establishing new care standards indicate a company managing complex multi-product GTM across global markets.
Tech Stack 67 technologies
What Johnson & Johnson MedTech Is Building
◆Challenges
- Adoption of full portfolio
- Network strategy
- Separating orthopaedics business
- Establishing new standard of care
- Supporting cardiac surgeons
- Market penetration
- Reducing waste
- Inventory availability and accuracy
- Program inefficiencies
- Improving patient access
▲Active Projects
- Impella product portfolio adoption
- Development and commercialization of intravascular lithotripsy (ivl)
- Clinical studies for ivl
- New product development
- Train ct/heart failure programs on impella
- Surgical implant readiness
- Driving growth across designated territory
- Gain distribution and utilization of impella rp
- Protocol development
- Customer immersion at 5.5 sites
Hiring Activity
Department
Seniority
Notable leadership hires: Program Director, Physician Program Director, Director Physician Programs, Physician Programs Director, Regulatory Affairs Director
